XML 70 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Balance Sheet Details
9 Months Ended
Sep. 30, 2012
Balance Sheet Details [Abstract]  
Balance Sheet Details

5. Balance Sheet Details

Inventory

Inventories are recorded at standard cost on a first-in, first-out basis. Inventories consist of the following (in thousands) as of:

 

                 
    September 30,
2012
    December 31,
2011
 

Raw materials

  $ 217     $ 353  

Work in progress

    371       495  

Finished goods

    5,091       5,699  
   

 

 

   

 

 

 
      5,679       6,547  

Reserve

    (662     (224
   

 

 

   

 

 

 

Net inventory

  $ 5,017     $ 6,323  
   

 

 

   

 

 

 

The Company reviews inventory periodically and reduces the carrying value of items considered to be slow moving or obsolete to their estimated net realizable value. The Company considers several factors in estimating the net realizable value, including shelf lives of raw materials, demand for its enzyme products and historical write-offs.

Property and equipment

Property and equipment is stated at cost and depreciated over the estimated useful lives of the assets (generally three to five years) using the straight-line method.

Property and equipment consists of the following (in thousands):

 

                 
    September 30,
2012
    December 31,
2011
 

Laboratory, machinery and equipment

  $ 28,171     $ 24,927  

Computer equipment

    4,305       3,031  

Furniture and fixtures

    880       0  

Construction in progress

    6,364       4,106  
   

 

 

   

 

 

 

Property and equipment, gross

    39,720       32,064  

Less: Accumulated depreciation and amortization

    (25,374     (24,258
   

 

 

   

 

 

 

Property and equipment, net

  $ 14,346     $ 7,806  
   

 

 

   

 

 

 

 

Construction in progress assets related primarily to equipment associated with the build out of the Company’s pilot bioprocess development plant and automation laboratory which the Company expects to place in service during the fourth quarter. The pilot bioprocess development plant is expected to have a useful life of 10 years. The lease for the Company’s new building commenced in June 2012 and depreciation will commence upon installation of the equipment, over their appropriate asset lives.

Depreciation of property and equipment is provided on the straight-line method over estimated useful lives as follows:

 

         

Laboratory equipment

    3-5 years  

Computer equipment

    3 years  

Furniture and fixtures

    5 years  

Machinery and equipment

    3-5 years  

Office equipment

    3 years  

Software

    3 years  

In conjunction with the signing of the Company’s facility lease agreement in June 2011, an analysis of all tenant improvements completed on the new building was performed. In accordance with authoritative guidance, it was concluded that the tenant improvements being funded through tenant allowances are assets of the landlord and not the Company as all tenant improvements will remain with the building, are not specific to the Company and all construction is controlled by the landlord. As such, tenant improvements not paid directly by the Company or controlled by the Company, as well as the respective liabilities were not recorded on the Company’s consolidated financial statements.

Accrued expenses

Accrued expenses consists of the following (in thousands):

 

                 
    September 30,
2012
    December 31,
2011
 

Employee compensation

  $ 2,064     $ 3,138  

Professional and outside services costs

    947       1,060  

Accrued interest on debt

    29       479  

Royalties

    592       1,202  

Accrued restructuring

    72       396  

Accrued taxes

    659       40  

Other

    0       204  
   

 

 

   

 

 

 
    $ 4,363     $ 6,519